跳至主要内容
临床试验/NCT01173575
NCT01173575已完成不适用

Assessment of the Efficacy of FOSFOMYCIN in Patients With Bacterial Infection

Infectopharm Arzneimittel GmbH25 个研究点 分布在 2 个国家目标入组 209 人开始时间: 2010年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
209
试验地点
25

研究概览

简要总结

This project aims to assess the clinical and microbiological efficacy of fosfomycin(FOM) in patients with bacterial infection.

Primary objective:

• To assess clinical and microbiological efficacy of FOM in patients with bacterial infection.

Secondary objectives:

  • To determine the rate and severity of unexpected adverse events.
  • To determine the mean duration of therapy with FOM in patients with bacterial infection.

Study design:

Multi-center, non-interventional study

详细描述

Please note that InfectoPharm Arzneimittel und Consilium GmbH has taken over sponsor responsibilities for all German sites of this clinical trial with Jannuary 2016 from J&P MEDICAL RESEARCH LTD.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients with bacterial infection receiving FOM for clinical purposes will be included into the analysis.

排除标准

  • 未提供

研究者

发起方
Infectopharm Arzneimittel GmbH
申办方类型
Industry
责任方
Sponsor

研究点 (25)

Loading locations...

相似试验